Infosys (INFY) filed a counterclaim against Cognizant Technology Solutions (CTSH) in a US court, accusing the company and its Chief Executive Officer Ravi Kumar of anticompetitive tactics, media outlets reported Friday, citing the lawsuit.
Cognizant was alleged to have misused sensitive information to hinder the growth of Infosys' health-care platform and poached key executives, the counterclaim in a Texas federal court said, according to the reports.
Cognizant subsidiary TriZetto had accused Infosys of stealing trade secrets.
Infosys is seeking a jury trial and asking the court to invalidate Cognizant's nondisclosure agreements and award damages, the reports said.
Infosys and Cognizant didn't immediately respond to requests for comments from MT Newswires.
Infosys shares were little changed in recent Friday trading, and Cognizant fell 0.6%
Price: 22.79, Change: +0.01, Percent Change: +0.04
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.